Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gliosarcoma × Immunotherapy, Adoptive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, B-Cell 12 Multiple Myeloma 9 Recurrence 8 Lymphoma, Mantle-Cell 8 Lymphoma 8 Burkitt Lymphoma 8 Leukemia, Myeloid, Acute 7 Carcinoma, Hepatocellular 7 Pancreatic Neoplasms 6 Lymphoma, Follicular 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia 5 Stomach Neoplasms 4 Neoplasms 4 Leukemia, B-Cell 4 Glioma 4 Colorectal Neoplasms 4 Nasopharyngeal Carcinoma 3 Melanoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Simpson-Golabi-Behmel syndrome 2 Sarcoma, Synovial 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2 Osteosarcoma 2

Interventions

Temozolomide 122 Radiotherapy 81 Bevacizumab 41 Radiation 30 Carmustine 26 Irinotecan 21 Erlotinib Hydrochloride 21 Magnetic Resonance Spectroscopy 18 Chemotherapy, Adjuvant 17 Surgical Procedures, Operative 13 O(6)-benzylguanine 13 Carboplatin 13 sargramostim 12 Radiotherapy, Intensity-Modulated 11 Radiotherapy, Conformal 11 Imatinib Mesylate 9 Thalidomide 8 Drug Therapy 8 motexafin gadolinium 7 Radiosurgery 7 Procarbazine 7 Gefitinib 7 Filgrastim 7 Cyclophosphamide 7 pembrolizumab 6 cediranib 6 Vorinostat 6 Sirolimus 6 Lomustine 6 Hydroxyurea 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664363 2023-02-17

ExCeL

Duke University

Phase 1 Terminated

3 enrolled 8 charts

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡